Lu et al20 specifically collected data about new-onset acute symptomatic seizures between January and February 2020 at 42 hospitals in the Hubei province, the epicenter of COVID-19 in China. They enrolled 304 patients, none with a prior history of epilepsy, 108 of whom had severe disease. Patients presented with acute cerebrovascular disease and systemic disorders which could provoke seizures, but without seizures, febrile seizures, or episodes of status epilepticus. Two patients had seizure-like events, diagnosed as seizure mimics due to acute stress reaction and hypocalcemia. The authors concluded that COVID-19 poses minimal risk for acute symptomatic seizures, though a significant portion of severely ill patients had increased potentially provocative risk factors. A limitation of this study was lack of routine or long-term EEG recordings to investigate these seizure-like episodes or to assess for subclinical seizures.